Call Options Transactions Made in Q4 2024 in Corvus Pharmaceuticals, Inc. (CRVS)
This table provides information about the institutional ownership of Corvus Pharmaceuticals, Inc. (CRVS) during Q4 2024. The information is specifically focused on institutions that hold call options of Corvus Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
631KNew |
$2.87M - $6.03M
|
631K
$2.69M
|
|
|
Feb 14, 2025
Q4 2024
|
Ikarian Capital, LLC
Dallas, TX |
BUY
|
CALL |
536K+ 245.58% |
$2.44M - $5.13M
|
754K
$3.21M
|
|
|
Feb 14, 2025
Q4 2024
|
Jane Street Group, LLC
New York, NY |
BUY
|
CALL |
162KNew |
$738K - $1.55M
|
162K
$691K
|
|
|
Feb 14, 2025
Q4 2024
|
Boothbay Fund Management, LLC
New York, NY |
BUY
|
CALL |
155K+ 242.63% |
$704K - $1.48M
|
219K
$931K
|
|
|
Feb 14, 2025
Q4 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
122K+ 323.4% |
$553K - $1.16M
|
159K
$678K
|
|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
CALL |
78.2K+ 132.77% |
$356K - $748K
|
137K
$584K
|
|
|
Feb 14, 2025
Q4 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
CALL |
28.4K+ 18.59% |
$129K - $272K
|
181K
$772K
|
|
|
Feb 13, 2025
Q4 2024
|
Adar1 Capital Management, LLC
Austin, TX |
BUY
|
CALL |
10KNew |
$45.5K - $95.6K
|
10K
$42.6K
|